Ground-Breaking Electroporation-based Intervention for PAROXysmal Atrial Fibrillation Treatment (BEAT PAROX-AF)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 292 participants.
Also called NCT05159492
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 292 participants
- Registry
-
NCT05159492
-
- Other papers using this trial's data
- Pulsed field vs radiofrequency ablation for paroxysmal atrial fibrillation: the BEAT PAROX-AF trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Austria, Belgium, Czechia, France, Germany
- Registry status
- Completed
Technical summary
Registry record NCT05159492. Randomized; single masking; primary purpose treatment. Start 2021-12-27 (actual); primary completion 2025-02-14 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ground-Breaking Electroporation-based Intervention for PAROXysmal Atrial Fibrillation Treatment (BEAT PAROX-AF)
- Acronym
- BEAT PAROX-AF
- Condition
- Atrial Fibrillation
- Intervention (Device)
- PVI using PEF
- Intervention (Device)
- PVI using CFRF
- Lead sponsor
- University Hospital, Bordeaux
- Collaborator
- Horizon 2020 - European Commission
Record details
- Record id
cardio:ct-nct05159492- Content hash
51e0e2c86320e50cf08b094120c078d0e2c702436cb130f3cb403ffc06329bf1